Apeloa Pharmaceutical Co Ltd
000739
Company Profile
Business description
Apeloa Pharmaceutical Co Ltd is a pharmaceutical company. It is engaged in research and development, manufacturing and marketing of APIs formulations and veterinary drugs. It offers products including Ofloxacin, Levofloxacin Hydrochloride, Marbofloxacin, and others.
Contact
No. 399, Jiangnan Road
Hengdian, Zhejiang Province
Dongyang322118
CHNT: +86 57986557527
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
7,060
Stocks News & Analysis
stocks
Overvalued ASX share as market underestimates downside risks
Growth outlook solid, but upside more than priced in.
stocks
New production imminent for undervalued ASX gas play
LNG project receives first commissioning gas.
stocks
Going into earnings, is Tesla stock a buy, a sell, or fairly valued?
Awaiting more info on robotaxis and lower cost models, here’s what we think of Tesla stock.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,324.60 | 40.80 | 0.44% |
| CAC 40 | 8,201.98 | 27.78 | 0.34% |
| DAX 40 | 24,226.46 | 395.47 | 1.66% |
| Dow JONES (US) | 46,469.36 | 278.75 | 0.60% |
| FTSE 100 | 9,405.20 | 50.63 | 0.54% |
| HKSE | 25,858.83 | 611.73 | 2.42% |
| NASDAQ | 22,915.18 | 235.21 | 1.04% |
| Nikkei 225 | 49,185.50 | 1,603.35 | 3.37% |
| NZX 50 Index | 13,344.96 | 55.75 | 0.42% |
| S&P 500 | 6,715.45 | 51.44 | 0.77% |
| S&P/ASX 200 | 9,031.90 | 43.70 | 0.49% |
| SSE Composite Index | 3,863.89 | 24.14 | 0.63% |